SBC Stock Analysis: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$3.25
0.08 (2.52%)
▲
5d:
+2.2%
30d:
+1.56%
90d:
-26.14%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SBC shows positive signals but monitor for confirmation. Market pricing in 5.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SBC shows positive signals but monitor for confirmation. Market pricing in 5.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.64
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$2.88
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $3.25, which is considered extended relative to its 30-day fair value range of $2.97 to $3.19. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.7) compared to its historical average (7.8). Remarkably, the market is currently pricing in an annual earnings decline of 5.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBC is in a strong downtrend. Immediate support is located at $2.96, while resistance sits at $3.55.
Market Sentiment: SBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+161.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBC is in a strong downtrend. Immediate support is located at $2.96, while resistance sits at $3.55.
Market Sentiment: SBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+161.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.97 -
$3.19
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 161.5% below Wall St target ($8.50)
Trading Range Analysis
30-Day Trading Range
$2.97 -
$3.19
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.96
Resistance Level
$3.55
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.70
Wall Street Target
$8.50
(+161.5%)
Revenue Growth (YoY)
-9.0%
Earnings Growth (YoY)
-47.1%
Profit Margin
24.1%
Valuation Discount vs History
-5.0% cheaper
PE vs Historical
6.7 vs 7.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.0%
(market-implied from PE analysis)
1-Year Target
$3.09
(-5%)
2-Year Target
$2.93
(-10%)
3-Year Target
$2.79
(-14%)
3-Yr Target (if PE normalizes)
(PE: 7→8)
$3.24
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 4.3%)
$11.99
(+269%)
Base:
(SPY PE: 6.7, Growth: 4.3%)
$3.69
(+14%)
Bear:
(PE: 5.7, Growth: 4.3%)
$3.13
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (8x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 7.92 | Current EPS (TTM): $0.40
Bull Case
$4.23
(+30%)
Analyst growth 21.2%, PE expands to 8.7
Base Case
$3.84
(+18%)
Market implied 21.2%, PE stable at 7.9
Bear Case
$2.16
(-34%)
Severe decline -20.0%, PE contracts to 6.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.7 to 7.8
Stabilization Target:
$3.78
(+16.4%)
PE Expansion Potential:
+16.4%
Share & Embed Analysis
Last updated: July 03, 2026 6:20 PM ET
Data refreshes hourly during market hours. Next update: 7:20 PM
Data refreshes hourly during market hours. Next update: 7:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Yoshiyuki Aikawa
SELL
3100000 shares
2026-04-21
Yoshiyuki Aikawa
SELL
4422900 shares
2026-03-06
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
BUY
23 analysts |
$222 | 60 HOLD |
|
VRSK
Verisk Analytics Inc |
HOLD
18 analysts |
$220 | 64 BUY |
|
HURN
Huron Consulting Group I… |
STRONG BUY
5 analysts |
$184 | 56 HOLD |
|
BAH
Booz Allen Hamilton Hold… |
HOLD
14 analysts |
$95 | 60 HOLD |
|
ICFI
ICF International Inc |
BUY
5 analysts |
$105 | 60 BUY |
